Cancer BiologybioRxivPreprint
Anti-tumor effects of an Id antagonist with no acquired resistance
P. M. Wojnarowicz, M. G. Escalono, Y.-H. Huang…·R. Benezra
This study demonstrates that AGX51, an Id antagonist, effectively inhibits tumor growth in multiple cancer models without inducing acquired resistance.
DOI 10.1101/2020.01.06.894840